The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up UPDATE

Tue, 07th Oct 2014 09:45

African Minerals: Canaccord Genuity lowers target price from 20p to 15p with a hold recommendation.Aggreko: Exane initiates with a target price of 1500p and an underperform rating.Amec: Liberum Capital cuts target price from 1035p to 908p staying with its sell recommendation.Antofagasta: Canaccord Genuity reduces target price from 835p to 790p maintaining a hold recommendation. Nomura cuts target price from 720p to 700p, while upgrading to neutral.Arrow Global: Numis raises target price from 287p to 326p upgrading to buy.AstraZeneca: Deutsche Bank raises target price from 4000p to 4100p and stays with its hold recommendation. Panmure Gordon raises target price from 4400p to 4700p upgrading from hold to buy.Avon Rubber: N+1 Singer ups target price from 720p to 750p and keeps its buy recommendation.BAE Systems: Cantor Fitzgerald downgrades to hold with a target price of 460p.BHP Billiton: Canaccord Genuity cuts target price from 2020p to 1950p and retains a hold recommendation.BTG: Deutsche Bank raises target price from 655p to 745p keeping a buy recommendation.Central Asia Metals: Canaccord Genuity ups target price from 190p to 210p keeping a buy recommendation.Cranswick: N+1 Singer reduces target price from 1291p to 1246p reiterating a hold recommendation.Dixons Carphone: UBS initiates with a target price of 415p and a buy recommendation.easyJet: JP Morgan reduces target price from 1909p to 1815p and keeps an overweight rating.GlaxoSmithKline: Deutsche Bank cuts target price from 1450p to 1420p staying with a hold recommendation.Gooch & Housego: Investec cuts target price from 740p to 720p downgrading to add.Hummingbird Reources: Northland lowers target price from 98p to 94.2p and reiterates a buy recommendation.Hunting: Liberum Capital cuts target price from 802p to 763p downgrading to sell.ITE Group: Westhouse Securities cuts target price from 216p to 193p, while upgrading from neutral to add.John Wood Group: Liberum Capital reduces target price from 736p to 610p downgrading to sell.Kazakhmys: Canaccord Genuity ups target price from 260p to 280p maintaining a hold recommendation.Management Consulting: Canaccord Genuity lowers target price from 28p to 22p downgrading from buy to a speculative buy recommendation. Peel Hunt lowers target price from 30p to 21p and downgrades from buy to hold.Metminco: Canaccord Genuity lowers target price from 10p to 70p and keeps its speculative buy recommendation.Next Fifteen Communications: Canaccord Genuity shifts target price from 145p to 151p retaining a buy recommendation. Investec sOrsu Metals: Canaccord Genuity lowers target price from 4p to 3p and stays with its speculative buy recommendation.Petroceltic: Westhouse Securities downgrades to neutral with a target price of 240p.Petrofac: Liberum Capital reduces target price from 1223p to 1112p and keeps a hold recommendation.Pure Wafer: WH Ireland cuts target price from 115p to 96p, while leaving its buy recommendation unchanged.Rio Tinto: Canaccord Genuity reduces target price from 4165p to 4080p staying with its buy recommendation.Robert Walters: Oriel upgrades from add to buy.Sinclair IS Pharma: N+1 Singer lowers target price from 40p to 36p maintaining a buy recommendation.Spirent: Investec cuts target price from 105p to 80p, while its hold recommendation is kept.
More News
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.